All the news

  • DAAs safe and effective in elderly people with HCV

    Michael Carter / 05 September 2018

    Treatment with direct-acting antivirals (DAAs) is safe and effective in elderly people with hepatitis C virus (HCV) infection, according to German research published in Drugs & Aging. Elderly people (aged 70 years ...

  • New EACS treatment guidelines

    Keith Alcorn / 31 October 2017

    Everyone with HIV and hepatitis C virus (HCV) co-infection should receive direct-acting antiviral treatment for hepatitis C and should receive the same treatment for hepatitis C as people with hepatitis C monoinfection, ...

  • Liver disease a major cause of illness and death across the EU: action needed to save lives

    Michael Carter / 10 April 2013

    Liver disease is the cause of a considerable burden of illness across the European Union (EU), investigators report in The Journal of Hepatology. The authors calculate that 170,000 deaths each year are attributable ...

← First1Next →